Objective. Previously, it was shown that a lipidic emulsion (LDE) composed
of phospholipids and cholesterol esters which binds to low-density lipoprot
ein (LDL) receptors may concentrate in acute myeloid leukemia cells. In thi
s study, we aimed to verify whether LDE also has the ability to concentrate
in malignant ovarian cancer after being injected into the blood circulatio
n of the patients.
Methods. Three groups of women scheduled for surgery were included in the s
urvey: 13 bearing malignant tumors, 9 with benign ovarian tumors, and 13 wi
thout ovarian tumor who were scheduled to undergo oophorectomy due to malig
nant disease of the uterine cervix or endometrium. On the day prior to surg
ery they were injected with LDE labeled with [C-14]cholesteryl oleate, Spec
imens of tumors and normal ovaries excised during surgery were lipid extrac
ted and analyzed for radioactivity counting. Results were expressed in radi
oactive count (cpm) per gram of tissue.
Results. The mean of the uptakes of the emulsion radioactivity by the malig
nant tumors was roughly eightfold greater when compared with that of the co
ntralateral normal ovaries (2261 +/- 1444 and 275 +/- 137 cpm/g, respective
ly, P < 0.012), benign tumors, and normal ovaries of the patients without o
varian tumors.
Conclusion. LDE has the ability to concentrate in malignant ovarian tumor t
issue. Therefore, it can be used as a vehicle to direct cytotoxic drugs aga
inst malignant ovarian tumors, thus diminishing the side effects of chemoth
erapy, (C) 2001 Academic Press.